Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 833 results for "merck co"

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo
Pharma Letter

Merck & Co., Inc. To Present New Data In Five Tumor Types From...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of data from ongoing clinical trials evaluating the anti-tumor activity of pembrolizumab, the company's ... BioSpace, 8 hours ago
[x]  

48 images for merck co

Orlando Sentinel, 1 week ago
Dividend.com, 6 days ago
Jutia Group, 6 days ago
Pharma Letter, 1 week ago
Lawyer Herald, 1 week ago
Yahoo! News, 1 week ago
Reuters, 1 week ago
The Guardian Express, 2 weeks ago
Sky News Australia, 2 weeks ago
Jutia Group, 2 weeks ago

Potential Merck (MRK) Trade Has 2.71% Downside Protection

Sep 02, 2014 (Marketintelligencecenter.com via COMTEX News Network) -- MarketIntelligenceCenter.com's patented algorithms have selected a trade on Merck & Co Inc. ( MRK ) that returns 7.87% in 81 days for an annualized return rate of 35%. This ...
 PredictWallStreet6 hours ago Potential Merck (MRK) Trade Has 2.94% Downside Protection  Individual.com5 days ago Potential Merck (MRK) Trade Has 5.07% Downside Protection  Individual.com1 week ago Potential Merck (MRK) Trade Has 5.78% Downside Protection  Individual.com1 week ago
Bio Spectrum Asia

Merck & Co inks pact with Advaxis

Singapore : Merck has collaborated with Advaxis to study the combination of Advaxis's Lm-LLO cancer immunotherapy, and pembrolizumab Merck's investigational anti PD-1 antibody, for the treatment of prostate cancer. The collaboration will evaluate ...
 Bio Spectrum Asia4 days ago ADXS: Advaxis Enters Into Collaboration with Merck Using its Immunotherapy for the Treatment of Prostate …  Yahoo! Finance6 days ago Advaxis and Merck & Co collaborate on prostate cancer26-08-2014  Pharma Letter1 week ago Merck Co pens prostate cancer pact with Advaxis  Big News Network1 week ago
[x]  
Reuters India

Pfizer to test Xalkori lung cancer drug with Merck

NEW YORK: Pfizer has said it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest US ...
 The Gulf Today2 days ago Merck Collaborates With Pfizer Again For Its PD-1 Immunotherapy  Bidness Etc6 days ago Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  Yahoo! Finance1 week ago Pfizer looks to Merck's experimental immunotherapy to boost outcomes for lung cancer drug  MedCity News1 week ago
[x]  

Will This Coverage Initiation Help Merck (MRK) Stock Today?

NEW YORK (TheStreet) --aDeutscheainitiated coverage on Mercka with a "hold" rating and a $63 price target based on valuation. The stock closed at $60.20 on Tuesday. Must Read: Warren Buffett's 25 Favorite Stocks STOCKS TO BUY: TheStreet Quant ...
 TheStreet.com6 days ago Why Merck (MRK) Stock Is Gaining Today  TheStreet.com1 week ago
Motley Fool

3 Reasons Merck & Co., Inc.'s Stock Could Fall

If you were lucky enough to time your purchase of Merck (NYSE: MRK Merck has a couple of key catalysts on the horizon. These include an upcoming decision on breakthrough therapy-designated drug pembrolizumab by the Food and Drug Administration, the ...
 Motley Fool5 days ago

Merck receives FDA approval for insomnia drug

(MarketLine via COMTEX News Network) -- Merck & Co., Inc. has received approval from the FDA for BELSOMRA for adults with insomnia who have difficulty falling asleep and/or staying asleep. BELSOMRA is a highly selective antagonist for orexin ...
 PredictWallStreet4 days ago Merck's Melanoma Drug To Get FDA Approval Earlier Than Expected  Bidness Etc1 week ago U.S. FDA approves Merck insomnia drug  Reuters2 weeks ago Merck nausea drug works in children in late-stage trial  Reuters2 months ago

Analysts' Actions: Akamai, Bristol-Myers, Eli Lilly, Merck, Pfizer

TheStreet Staff 08/27/14 - 08:30 AM EDT NEW YORK ( TheStreet ) -- RATINGS CHANGES Akamai ( AKAM ) was initiated with an outperform rating at Robert Baird. Twelve-month price target is $71. Company is an industry leader that can benefit ...
 TheStreet.com6 days ago
Reuters India

Merck cancer immunotherapeutic may get the nod soon

09:24 ET | About: Merck & Co Inc. (MRK) According to Reuters , the FDA may clear Merck's (NYSE:MRK) anti-PD-1 Ab pembrolizumab for the treatment of patients with melanoma who are not responding to Yervoy (ipilimumab) (NYSE:BMY) in the next several ...
 Seeking Alpha1 week ago Merck's PD-1 Inhibitor May be Approved Earlier Than Anticipated  American Journal of Managed Care1 week ago U.S. Approval Of Merck & Co., Inc. Cancer Immunotherapy Expected Soon  BioSpace1 week ago Exclusive: U.S. approval of Merck cancer immunotherapy expected soon  Yahoo! Malaysia1 week ago
[x]  

Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk

Research and Markets (http://www.researchandmarkets.com/research/6xznb6/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" report to their offering. Hormone replacement therapy, also known as ...
 Individual.com1 week ago Global Hodgkins Lymphoma Therapeutics Market 2014-2018: Bristol Myers Squibb, F. Hoffmann-La Roche, Merck & Co & Pfizer Dominate the Industry  Individual.com1 week ago Research and Markets: Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk  Morningstar.com1 week ago RESEARCH AND MARKETS : Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less